デフォルト表紙
市場調査レポート
商品コード
990749

抗凝固薬の拮抗薬の世界市場:製品、流通チャネル、地域別分析、COVID-19の影響、2027年までの予測

Anticoagulant Reversal Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product, and Distribution channel and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 154 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.57円
抗凝固薬の拮抗薬の世界市場:製品、流通チャネル、地域別分析、COVID-19の影響、2027年までの予測
出版日: 2021年01月29日
発行: The Insight Partners
ページ情報: 英文 154 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗凝固薬の拮抗薬の市場規模は、2019年に9億2,255万米ドルとなりました。同市場は、2020年から2027年にかけて12.6%のCAGRで成長する見通しで、2027年には22億7,654万米ドルに達すると予測されています。同市場の成長は、主に心房細動(AFib)と脳卒中の有病率の上昇に起因しています。ただし、抗凝固薬の拮抗薬の高いコストは市場成長の妨げとなっています。

当レポートは、世界の抗凝固薬の拮抗薬市場について調査しており、市場収益や予測、機会や動向、成長および抑制要因、COVID-19パンデミックの影響、製品・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 要点

第3章 調査手法

第4章 市場情勢

  • 概要
  • PEST分析
  • 専門家の見解

第5章 市場力学

  • 市場の成長要因
  • 市場の抑制要因
  • 市場機会
  • 今後の動向
  • 影響分析

第6章 世界市場分析

  • 市場の収益予測と分析
  • 地域別市場予測と分析
  • 市場の位置づけ

第7章 市場分析:製品別

  • 概要
  • 市場シェア(2019、2027)
  • プロトロンビン複合体濃縮物
  • ビタミンK
  • プロタミン
  • トラネキサム酸
  • イダルシズマブ
  • アンデキサネットアルファ(Andexxa)

第8章 市場分析:流通チャネル別

  • 概要
  • 市場シェア(2019、2027)
  • 病院薬局
  • 小売薬局
  • その他

第9章 市場分析:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 中東とアフリカ
  • 中南米

第10章 COVID-19パンデミックが市場に与える影響

  • 北米
  • 欧州
  • アジア太平洋
  • 中東とアフリカ
  • 中南米

第11章 業界情勢の展望

  • 概要
  • 市場企業の成長戦略
  • 有機的開発
  • 無機的開発

第12章 企業プロファイル

  • Boehringer Ingelheim International GmbH
  • Pfizer Inc.
  • Octapharma AG
  • AMAG PHARMACEUTICALS, INC.
  • Fresenius Kabi AG
  • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  • CSL Limited
  • China Biologic Products, Inc
  • Grifols, S.A.
  • Shanghai RAAS Blood Products Co., Ltd.

第13章 付録

  • 用語集
図表

List Of Tables

  • Table 1. North America Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 3. US Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 4. US Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 5. Canada Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 6. Canada Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Mexico Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Mexico Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Europe: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Europe: Anticoagulant Reversal Drugs Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Germany: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 13. France: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 14. France: Anticoagulant Reversal Drugs Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 15. UK: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 16. UK: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Italy: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Spain: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Rest of Europe: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Asia Pacific: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 24. Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 25. China: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 26. China: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Japan: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 29. India: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 30. India: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 31. South Korea: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 32. South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Australia: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Middle East & Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Middle East & Africa Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Saudi Arabia Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 40. Saudi Arabia Anticoagulant Reversal Drugs Market, Type - Revenue and Forecast to 2027 (USD Million)
  • Table 41. UAE Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 42. UAE Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 43. South Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 44. South Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 45. Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 46. Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 47. South and Central America: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 48. South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Brazil: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Argentina: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 53. Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 54. Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Glossary of Terms, Anticoagulant Reversal Drugs Market

List Of Figures

  • Figure 1. Anticoagulant Reversal Drugs Market Segmentation
  • Figure 2. Anticoagulant Reversal Drugs Market, By Region
  • Figure 3. Global Anticoagulant Reversal Drugs Market Overview
  • Figure 4. Prothrombin Complex Concentrates Segment Held Largest Share of Product Segment In Anticoagulant Reversal Drugs Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Anticoagulant Reversal Drugs Market, By Geography (USD Million)
  • Figure 7. Global Anticoagulant Reversal Drugs Market- Leading Country Markets (USD Million)
  • Figure 8. Global Anticoagulant Reversal Drugs Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East & Africa Analysis
  • Figure 13. South & Central America PEST Analysis
  • Figure 14. Expert Opinion
  • Figure 15. Anticoagulant Reversal Drugs Market Impact Analysis of Drivers and Restraints
  • Figure 16. Global Anticoagulant Reversal Drugs Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 17. Global Anticoagulant Reversal Drugs Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 18. Global Anticoagulant Reversal Drugs Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 19. Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
  • Figure 20. Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 21. Vitamin K: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 22. Protamine: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 23. Tranexamic Acid: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 24. Idarucizumab: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 25. Andexxa: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 26. Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
  • Figure 27. Hospital Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 28. Retail Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 29. Others: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 30. North America: Anticoagulant Reversal Drugs Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 31. North America Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
  • Figure 32. North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
  • Figure 33. US: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 34. Canada: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 35. Mexico: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 36. Europe: Anticoagulant Reversal Drugs Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 37. Europe: Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Europe: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
  • Figure 39. Germany: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 40. France: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 41. UK: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 42. Italy: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. Spain: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Rest of Europe: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Asia Pacific: Anticoagulant Reversal Drugs Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 46. Asia Pacific: Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Asia Pacific: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
  • Figure 48. China: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Japan: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. India: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. South Korea: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. Australia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. Middle East & Africa: Anticoagulant Reversal Drugs Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 55. Middle East & Africa Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
  • Figure 56. Middle East & Africa: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
  • Figure 57. Saudi Arabia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. UAE: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. South Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. Rest of Middle East and Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. South and Central America: Anticoagulant Reversal Drugs Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 62. South and Central America: Anticoagulant Reversal Drugs Market Revenue and Forecast to 2027 (USD Million)
  • Figure 63. South and Central America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
  • Figure 64. Brazil: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 65. Argentina: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. Rest of South and Central America: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 68. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 69. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 70. Impact of COVID-19 Pandemic in Middle East and Africa Market
  • Figure 71. Impact of COVID-19 Pandemic in South and Central America Market
  • Figure 72. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00004954

The anticoagulant reversal drugs market is expected to reach US$ 2,276.54 million in 2027 from US$ 922.55 million in in 2019; it is estimated to grow at a CAGR of 12.6% from 2020 to 2027.The growth of the anticoagulant reversal drugs market is mainly attributed to rising prevalence of atrial fibrillation (AFib) and stroke. However, the high cost of anticoagulant reversal drugs is restricting the market growth.

Anticoagulant reversal drugs are used in the management of hemorrhagic stroke to decrease ongoing bleeding and allow tissues to recover.

There has been an increase in stroke prevalence in low- and middle-income countries. As per the study 'Incidence & prevalence of stroke in India: A systematic review' published in 2017, the cumulative frequency of stroke in India ranged from 105 to 152/100,000 persons per year. Thus, the incidence and prevalence of stroke in India are higher than those of high-income countries.

Additionally, as per the CDC, in 2018, one in every six deaths in the US from cardiovascular disease was due to stroke. It also mentioned that in the US, in every 40 seconds, someone has a stroke, and in every 4 minutes, someone dies of a stroke.

As per the report 'Burden of Stroke in Europe' in 2017, there were 1.12 million incident strokes, 9.53 million stroke survivors, 0.46 million deaths, and 7.06 million disability-adjusted life years lost because of stroke in the European Union.

Based on product, the anticoagulant reversal drugs market is segmented into prothrombin complex concentrates, vitamin k, protamine, tranexamic acid, idarucizumab, and AndeXXa. The prothrombin complex concentrates segment held the largest share of the market in 2019; whereas, the AndeXXa segment is estimated to register the highest CAGR in the market during the forecast period. Based on distribution channel, the anticoagulant reversal drugs market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019, and is estimated to register the highest CAGR in the market during the forecast period.

The World Health Organization, National Health Service, Centers for Disease Control and Prevention, European Pharmacy Network, and European Society of Cardiology, along with company websites, are the major primary and secondary sources cited while preparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the anticoagulant reversal drugs market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global anticoagulant reversal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Anticoagulant Reversal Drugs Market - By Product
    • 1.3.2 Global Anticoagulant Reversal Drugs Market - By Distribution Channel
    • 1.3.3 Global Anticoagulant Reversal Drugs Market - By Geography

2. Anticoagulant Reversal Drugs Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Anticoagulant Reversal Drugs Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America- PEST Analysis
    • 4.2.2 Europe- PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East & Africa
    • 4.2.5 South & Central America
  • 4.3 Expert Opinion

5. Anticoagulant Reversal Drugs Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Atrial Fibrillation (AFib)
    • 5.1.2 Increase in Prevalence of Stroke
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Anticoagulant Reversal Drugs
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Research Activities on Anticoagulant Reversal Drugs
  • 5.4 Future Trends
    • 5.4.1 Development and Launch of Innovative Products
  • 5.5 Impact Analysis

6. Anticoagulant Reversal Drugs Market - Global Analysis

  • 6.1 Global Anticoagulant Reversal Drugs Market Revenue Forecast And Analysis
  • 6.2 Global Anticoagulant Reversal Drugs Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning

7. Anticoagulant Reversal Drugs Market- By Product

  • 7.1 Overview
  • 7.2 Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
  • 7.3 Prothrombin Complex Concentrates
    • 7.3.1 Overview
    • 7.3.2 Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 7.4 Vitamin K
    • 7.4.1 Overview
    • 7.4.2 Vitamin K: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 7.5 Protamine
    • 7.5.1 Overview
    • 7.5.2 Protamine: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 7.6 Tranexamic Acid
    • 7.6.1 Overview
    • 7.6.2 Tranexamic Acid: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 7.7 Idarucizumab
    • 7.7.1 Overview
    • 7.7.2 Idarucizumab: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 7.8 Andexxa
    • 7.8.1 Overview
    • 7.8.2 Andexxa: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)

8. Anticoagulant Reversal Drugs Market- By Distribution Channel

  • 8.1 Overview
  • 8.2 Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
  • 8.3 Hospital Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Hospital Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 8.4 Retail Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Retail Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)

9. Anticoagulant Reversal Drugs Market - Geographic Analysis

  • 9.1 North America: Anticoagulant Reversal Drugs Market
    • 9.1.1 Overview
    • 9.1.2 North America: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
    • 9.1.3 North America: Anticoagulant Reversal Drugs Market, by Product, 2018-2027 (USD Million)
    • 9.1.4 North America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
    • 9.1.5 North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
    • 9.1.6 US: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.1 US: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.2 US: Anticoagulant Reversal Drugs Market, by Product, 2018-2027 (USD Million)
      • 9.1.6.3 US: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018-2027 (USD Million)
    • 9.1.7 Canada: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.1 Canada: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.2 Canada: Anticoagulant Reversal Drugs Market, by Product, 2018-2027 (USD Million)
      • 9.1.7.3 Canada: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018-2027 (USD Million)
    • 9.1.8 Mexico: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.1 Mexico: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.2 Mexico: Anticoagulant Reversal Drugs Market, by Product, 2018-2027 (USD Million)
      • 9.1.8.3 Mexico: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018-2027 (USD Million)
  • 9.2 Europe: Anticoagulant Reversal Drugs Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
    • 9.2.3 Europe: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 9.2.4 Europe: Anticoagulant Reversal Drugs Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.2.5 Europe: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
    • 9.2.6 Germany: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.1 Germany: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.2 Germany: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.3 Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.2.7 France: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.1 France: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.2 France: Anticoagulant Reversal Drugs Market, by Product- Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.3 France: Anticoagulant Reversal Drugs Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.2.8 UK: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.1 UK: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.2 UK: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.3 UK: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.2.9 Italy: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.1 Italy: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.2 Italy: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.3 Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.2.10 Spain: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.1 Spain: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.2 Spain: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.3 Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.2.11 Rest of Europe: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.11.1 Rest of Europe: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.11.2 Rest of Europe: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.2.11.3 Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 9.3 Asia Pacific: Anticoagulant Reversal Drugs Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
    • 9.3.3 Asia Pacific: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 9.3.4 Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.3.5 Asia Pacific: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
    • 9.3.6 China: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.1 China: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.2 China: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.3 China: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.3.7 Japan: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.1 Japan: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.2 Japan: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.3 Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.3.8 India: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.1 India: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.2 India: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.3 India: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.3.9 South Korea: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.1 South Korea: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.2 South Korea: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.3 South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.3.10 Australia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.1 Australia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.2 Australia: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.3 Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.3.11 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.11.1 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.11.2 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.3.11.3 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 9.4 Middle East & Africa: Anticoagulant Reversal Drugs Market
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
    • 9.4.3 Middle East & Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 9.4.4 Middle East & Africa Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.4.5 Middle East & Africa: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
    • 9.4.6 Saudi Arabia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.1 Saudi Arabia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.2 Saudi Arabia Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.3 Saudi Arabia Anticoagulant Reversal Drugs Market, Type - Revenue and Forecast to 2027 (USD Million)
    • 9.4.7 UAE: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.1 UAE: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.2 UAE Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.3 UAE Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.4.8 South Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.1 South Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.2 South Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.3 South Africa Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.4.9 Rest of Middle East and Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.9.1 Rest of Middle East and Africa: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.9.2 Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.4.9.3 Rest of Middle East and Africa Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • 9.5 South and Central America: Anticoagulant Reversal Drugs Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
    • 9.5.3 South and Central America: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 9.5.4 South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.5.5 South and Central America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
    • 9.5.6 Brazil: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.1 Brazil: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.2 Brazil: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.3 Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.5.7 Argentina: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.1 Argentina: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.2 Argentina: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.3 Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.5.8 Rest of South and Central America: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.8.1 Rest of South and Central America: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.8.2 Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.5.8.3 Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

10. Impact of COVID-19 Pandemic on Global Anticoagulant Reversal Drugs Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Anticoagulant Reversal Drugs Market- Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market, (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
    • 11.3.2 Organic Developments Done By Companies
  • 11.4 Inorganic Developments
    • 11.4.1 Overview
    • 11.4.2 Inorganic Developments Done By Companies

12. Company Profiles

  • 12.1 Boehringer Ingelheim International GmbH
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Pfizer Inc.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Octapharma AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 AMAG PHARMACEUTICALS, INC.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Fresenius Kabi AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 CSL Limited
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 China Biologic Products, Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Grifols, S.A.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Shanghai RAAS Blood Products Co., Ltd.
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 Glossary of Terms